iTeos Therapeutics Inc. (ITOS) Fundamentals

ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody.
SHARE INFORMATION
Market Cap$ 842,314,685
Shares Outstanding35,540,704
Float23,362,295
Percent Float65.73%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 344,775,000
Latest Fiscal EPS$ 5.61
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions384
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months5,898,167
Institutional Holdings Percent139.5%
Institutional Sold Previous 3 Months7,639,086
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months-
Insider Holdings Percent0.3
Insider Sold Previous 3 Months1,038,000
Insider Shares Owned94,364
TRADING INFO
52 Week High$ 52.43
52 Week Low$ 16.21
52 Week High Change$ -5.28
21 Day Moving Average$ 25.5319
21 Day Extended Moving Average$ 25.1716
50 Day Moving Average$ 22.5158
50 Day Extended Moving Average$ 24.1961
200 Day Moving Average$ 30.5638
200 Day Extended Moving Average$ 27.3906
10 Day Average Volume312,338
20 Day Average Volume334,998
30 Day Average Volume361,411
50 Day Average Volume426,418
Alpha0.015787
Beta1.4975
Standard Deviation0.222767
R20.121008
7 Day Price Change$ -3.35
7 Day Percent Change-12.38%
21 Day Price Change$ -2.28
21 Day Percent Change-8.78%
30 Day Price Change$ 0.53
30 Day Percent Change2.29%
Month to Date Price Change$ -0.76
Month to Date Percent Change-3.11%
Quarter to Date Price Change$ 3.10
Quarter to Date Percent Change15.05%
180 Day Price Change$ -11.41
180 Day Percent Change-32.5%
200 Day Price Change$ -12.39
200 Day Percent Change-34.33%
Year to Date Price Change$ -22.86
Year to Date Percent Change-49.1%

iTeos Therapeutics Inc. (ITOS) Key Ratios

PROFITABILITY
EBIT Margin78.5%
EBITDA Margin78.6%
Pre-Tax Profit Margin0.0%
Profit Margin Count65.17%
Gross Margin0.0%
Profit Margin TOT65.17%
INCOME STATEMENTS
Revenue$ 497,297,000
Revenue Per Share$ 13.9787
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.50
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio4.80
Leverage Ratio1.50
Quick Ratio4.80
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio3.50
Enterprise Value$ 144,060,671
Price to Sales1.6954
Price to Free Cash1.80
PE High Last 5 Years0.00
Price To Book1.50
Price To Cash Flow2.10
PE Low Last 5 Years0.00
Price to Tangible Book1.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover77.10
Invoice Turnover0.00
Assets Turnover0.50
Return Assets50.31
Return on Equity63.40
Return on Capital62.84

iTeos Therapeutics Inc. (ITOS) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorDeloitte Bedrijfsrevisoren / Reviseurs d┬┐Entreprises
CEOMichel Detheux
Emplyoees94
Last AuditUQ
CIK0001808865
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address321 Arsenal Street
Watertown, MA 2472
Websitehttps://www.iteostherapeutics.com
Facsimile-
Telephone+1 339 217-0161
Emailinfo@iteostherapeutics.com


Your Recent History
NASDAQ
ITOS
iTeos Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.